Paris, France

Nathalie Chereze

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Bourg la Reine, FR (2007 - 2013)
  • Paris, FR (2012 - 2014)

Company Filing History:


Years Active: 2007-2014

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Nathalie Chereze: Innovator in Therapeutic Compounds

Introduction

Nathalie Chereze is a prominent inventor based in Paris, France. She has made significant contributions to the field of therapeutic compounds, holding a total of 8 patents. Her work focuses on the development of innovative chemical compounds with potential therapeutic applications.

Latest Patents

Among her latest patents, Nathalie has developed derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds. This invention relates to a compound of the general formula (I), where R can be a hydrogen or fluorine atom, or a hydroxyl, cyano, trifluoromethyl, C-alkyl, C-alkoxy, or NRR group. The invention also includes the therapeutic use of these compounds. Another notable patent involves carbamate derivatives of alkyl-heterocycles, which also corresponds to a general formula (I). This compound features various groups, including phenyl, pyridinyl, and other heterocyclic structures, and is designed for therapeutic use.

Career Highlights

Nathalie Chereze has worked with notable companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. Her experience in these organizations has allowed her to contribute to the advancement of therapeutic innovations.

Collaborations

Throughout her career, Nathalie has collaborated with esteemed colleagues such as Mourad Saady and Philippe Yaiche. These partnerships have further enriched her research and development efforts.

Conclusion

Nathalie Chereze is a distinguished inventor whose work in therapeutic compounds has the potential to impact the medical field significantly. Her innovative patents and collaborations highlight her dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…